Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for Parkinson’s disease is a research paper published in Expert Opinion on Investigational Drugs (2020). On theSindex it has a DataRank of 0.621. It has been cited 62 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.621
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Swedish Research Council
Grant: K2012-62X-03185-42-4
Intramural NIH HHS
Grant: Z99 AG999999
Intramural Research Program of the National Institute on Aging, National Institutes of Health, USA
Grant: AG 000333
Intramural NIH HHS
Grant: ZIA AG000333
FWCI
4.16
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Attenuating mitochondrial dysfunction and morphological disruption with PT320 delays dopamine degeneration in MitoPark mice
Additional file 1 of Attenuating mitochondrial dysfunction and morphological disruption with PT320 delays dopamine degeneration in MitoPark mice